http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2489010-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aac141a3051e128a54ab3843e7aa47e2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate | 2003-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fcfe6f97b90646bb83316921642b001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74dbd2b9a82846c49328024ab80142c9 |
| publicationDate | 2012-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2489010-C |
| titleOfInvention | Bisacyloxypropylcysteine conjugates and their use |
| abstract | The invention relates to novel lipopeptide conjugates, in which a cysteine that is double-substituted by a fatty acid is bonded by means of the carboxyl group to a highly soluble, physiologically compatible and non-immunogenic, polymeric conjugate group. The novel conjugates exhibit an excellent macrophage stimulant action and do not require additional solutizing. They can be used in a wide range of applications, in particular for stimulating macrophages, for stimulating antibody synthesis, for combating infection, as an immunostimulant, in particular in relation to tumours, for preventing and treating septicaemic shock, for wound healing and as an adjuvant for vaccines. |
| priorityDate | 2002-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 109.